{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:42:53Z","timestamp":1790397773121,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T00:00:00Z","timestamp":1570492800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T00:00:00Z","timestamp":1570492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11096-019-00909-0","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T06:37:46Z","timestamp":1570516666000},"page":"1491-1498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Integrating a pharmacist into an anaesthesiology and critical care department: Is this worthwhile?"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0076-6335","authenticated-orcid":false,"given":"C.","family":"Chapuis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Albaladejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Billon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Catoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chanoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Allenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bouzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bedouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"Payen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,8]]},"reference":[{"issue":"3","key":"909_CR1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/CCM.0b013e318236f473","volume":"40","author":"SL Kane-Gill","year":"2012","unstructured":"Kane-Gill SL, Kirisci L, Verrico MM, Rothschild JM. Analysis of risk factors for adverse drug events in critically ill patients. Crit Care Med. 2012;40(3):823\u20138.","journal-title":"Crit Care Med"},{"issue":"10","key":"909_CR2","first-page":"2007","volume":"29","author":"RJ Brilli","year":"2001","unstructured":"Brilli RJ, Spevetz A, Branson RD, Campbell GM, Cohen H, Dasta JF, Harvey MA, Kelley MA, Kelly KM, Rudis MI, St Andre AC, Stone JR, Teres D, Weled BJ. American college of critical care medicine task force on models of critical care delivery. The american college of critical care medicine guidelines for the definition of an intensivist and the practice of critical care medicine. Crit Care Deliv Intensive Care Unit Defin Clinl Roles Best Pract Model Crit Care Med. 2001;29(10):2007\u201319.","journal-title":"Crit Care Deliv Intensive Care Unit Defin Clinl Roles Best Pract Model Crit Care Med."},{"key":"909_CR3","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1097\/00003246-200011000-00037","volume":"28","author":"MI Rudis","year":"2000","unstructured":"Rudis MI, Brandl KM. Position paper on critical care pharmacy services. Crit Care Med. 2000;28:3746\u201350.","journal-title":"Crit Care Med"},{"key":"909_CR4","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1345\/aph.1L375","volume":"42","author":"B Erstad","year":"2008","unstructured":"Erstad B. A primer on critical care pharmacy services. Ann Pharmacother. 2008;42:1871\u201381.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"909_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jama.282.3.267","volume":"282","author":"LL Leape","year":"1999","unstructured":"Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282(3):267\u201370.","journal-title":"JAMA"},{"issue":"2","key":"909_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/01.CCM.0000300275.63811.B3","volume":"36","author":"J Marshall","year":"2008","unstructured":"Marshall J, Finn CA, Theodore AC. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med. 2008;36(2):427\u201333.","journal-title":"Crit Care Med"},{"issue":"5","key":"909_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00134-003-1705-3","volume":"29","author":"SL Kane","year":"2003","unstructured":"Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29(5):691\u20138.","journal-title":"Intensive Care Med"},{"issue":"5","key":"909_CR8","doi-asserted-by":"publisher","first-page":"R174","DOI":"10.1186\/cc9278","volume":"14","author":"JE Klopotowska","year":"2010","unstructured":"Klopotowska JE, Kuiper R, van Kan HJ, de Pont AC, Dijkgraaf MG, Lie-A-Huen L, et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care. 2010;14(5):R174.","journal-title":"Crit Care"},{"issue":"23","key":"909_CR9","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.2146\/ajhp060674","volume":"64","author":"BJ Kopp","year":"2007","unstructured":"Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm. 2007;64(23):2483\u20137.","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"909_CR10","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1097\/CCM.0b013e31818f2269","volume":"36","author":"R MacLaren","year":"2008","unstructured":"MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008;36(12):3184\u20139.","journal-title":"Crit Care Med"},{"issue":"2","key":"909_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/CCM.0000000000002827","volume":"46","author":"G Leguelinel-Blache","year":"2018","unstructured":"Leguelinel-Blache G, Nguyen TL, Louart B, Poujol H, Lavigne JP, Roberts JA, Muller L, Kinowski JM, Roger C, Lefrant JY. Impact of quality bundle enforcement by a critical care pharmacist on patient outcome and costs. Crit Care Med. 2018;46(2):199\u2013207.","journal-title":"Crit Care Med"},{"issue":"4","key":"909_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00134-006-0072-2","volume":"32","author":"M Hartmann","year":"2006","unstructured":"Hartmann M, Meier-Hellmann A. How to increase return on investment of the intensive care pharmacist-fear of flying. Intensive Care Med. 2006;32(4):511\u20135.","journal-title":"Intensive Care Med"},{"issue":"9","key":"909_CR13","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/ajhp\/56.9.887","volume":"56","author":"ASHP guidelines on surgery and anesthesiology pharmaceutical services","year":"1999","unstructured":"ASHP guidelines on surgery and anesthesiology pharmaceutical services. American society of health-system pharmacists. Am J Health Syst Pharm. 1999;56(9):887\u201395.","journal-title":"Am J Health Syst Pharm"},{"issue":"8","key":"909_CR14","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/papr.12549","volume":"17","author":"AL Dezia","year":"2017","unstructured":"Dezia AL, Baccus TD, Natavio AM, Conroy SM, Hall LM. Implementation of a pharmacist-led patient-controlled analgesia dosing service. Pain Pract. 2017;17(8):990\u20138.","journal-title":"Pain Pract."},{"issue":"12","key":"909_CR15","first-page":"58","volume":"54","author":"JA Thomas","year":"2000","unstructured":"Thomas JA, Martin V, Frank S. Improving pharmacy supply-chain management in the operating room. Healthc Financ Manag. 2000;54(12):58\u201361.","journal-title":"Healthc Financ Manag."},{"issue":"5","key":"909_CR16","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1345\/aph.1D182","volume":"38","author":"JW van Mil","year":"2004","unstructured":"van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38(5):859\u201367.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"909_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/jcpt.12214","volume":"40","author":"P Bedouch","year":"2015","unstructured":"Bedouch P, Sylvoz N, Charpiat B, Juste M, Roubille R, Rose FX, et al. French society of clinical pharmacy\u2019s act-IP\u00a9 group. Trends in pharmacists\u2019 medication order review in French hospitals from 2006 to 2009: analysis of pharmacists\u2019 interventions from the act-IP\u00a9 website observatory. J Clin Pharm Ther. 2015;40(1):32\u201340.","journal-title":"J Clin Pharm Ther."},{"issue":"7","key":"909_CR18","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1345\/aph.1L045","volume":"42","author":"P Bedouch","year":"2008","unstructured":"Bedouch P, Charpiat B, Conort O, Rose FX, Escofier L, Juste M, et al. Assessment of clinical pharmacists\u2019 interventions in French hospitals: results of a multicenter study. Ann Pharmacother. 2008;42(7):1095\u2013103.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"909_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/pds.3415","volume":"22","author":"M Askari","year":"2013","unstructured":"Askari M, Eslami S, Louws M, Wierenga PC, Dongelmans DA, Kuiper RA, et al. Frequency and nature of drug\u2013drug interactions in the intensive care unit. Pharmacoepidemiol Drug Saf. 2013;22(4):430\u20137.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"909_CR20","doi-asserted-by":"publisher","first-page":"104.e1","DOI":"10.1016\/j.jcrc.2010.04.014","volume":"26","author":"A Rivkin","year":"2011","unstructured":"Rivkin A, Yin H. Evaluation of the role of the critical care pharmacist in identifying and avoiding or minimizing significant drug\u2013drug interactions in medical intensive care patients. J Crit Care. 2011;26(1):104.e1\u20136.","journal-title":"J Crit Care"},{"issue":"4","key":"909_CR21","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jcrc.2015.04.008","volume":"30","author":"R Shulman","year":"2015","unstructured":"Shulman R, McKenzie CA, Landa J, Bourne RS, Jones A, Borthwick M, et al. Protected-UK group. Pharmacist\u2019s review and outcomes: treatment-enhancing contributions tallied, evaluated, and documented (protected-UK). J Crit Care. 2015;30(4):808\u201313.","journal-title":"J Crit Care"},{"issue":"4","key":"909_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/ijpp.12304","volume":"25","author":"N Rudall","year":"2017","unstructured":"Rudall N, McKenzie C, Landa J, Bourne RS, Bates I, Shulman R. Protected-UK\u2014clinical pharmacist interventions in the UK critical care unit: exploration of relationship between intervention, service characteristics and experience level. Int J Pharm Pract. 2017;25(4):311\u20139.","journal-title":"Int J Pharm Pract."},{"issue":"8","key":"909_CR23","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00134-006-0218-2","volume":"32","author":"G Patel","year":"2006","unstructured":"Patel G, Loh-Trivedi M. Clinical pharmacists in the intensive care unit: is there really an equation? Intensive Care Med. 2006;32(8):1275\u20136 author reply 1277.","journal-title":"Intensive Care Med."},{"issue":"9","key":"909_CR24","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1097\/CCM.0b013e3181e8adcc","volume":"38","author":"S Kanji","year":"2010","unstructured":"Kanji S, Lam J, Johanson C, Singh A, Goddard R, Fairbairn J, et al. Systematic review of physical and chemical compatibility of commonly used medications administered by continuous infusion in intensive care units. Crit Care Med. 2010;38(9):1890\u20138.","journal-title":"Crit Care Med"},{"key":"909_CR25","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1097\/CCM.0b013e3181f8569b","volume":"38","author":"C Chapuis","year":"2010","unstructured":"Chapuis C, Roustit M, Bal G, Schwebel C, Pansu P, David-Tchouda S et al. Automated drug dispensing system reduces medication errors in an intensive care setting. Crit Care Med. 2010;38:2275\u201381.","journal-title":"Crit Care Med"},{"key":"909_CR26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13054-015-1041-3","volume":"19","author":"C Chapuis","year":"2015","unstructured":"Chapuis C, Bedouch P, Detavernier M, Durand M, Francony G, Lavagne P, et al. Automated drug dispensing systems in the intensive care unit: a financial analysis. Crit Care. 2015;19:318.","journal-title":"Crit Care"},{"issue":"2","key":"909_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12630-012-9853-y","volume":"60","author":"BA Orser","year":"2013","unstructured":"Orser BA, Hyland S, David U, Sheppard I, Wilson CR. Review article: improving drug safety for patients undergoing anesthesia and surgery. Can J Anaesth. 2013;60(2):127\u201335.","journal-title":"Can J Anaesth"},{"issue":"8","key":"909_CR28","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/jama.2011.1206","volume":"306","author":"CM Bell","year":"2011","unstructured":"Bell CM, Brener SS, Gunraj N, Huo C, Bierman AS, Scales DC, et al. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA. 2011;306(8):840\u20137.","journal-title":"JAMA"},{"issue":"1","key":"909_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/jac\/dkv288","volume":"71","author":"MH Abdul-Aziz","year":"2016","unstructured":"Abdul-Aziz MH, Lipman J, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, et al. DALI study group. Is prolonged infusion of piperacillin\/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic\/pharmacodynamic and patient outcomes? An observation from the defining antibiotic levels in intensive care unit patients (DALI) cohort. J Antimicrob Chemother. 2016;71(1):196\u2013207.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"909_CR30","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1378\/chest.12-1615","volume":"144","author":"CR Preslaski","year":"2013","unstructured":"Preslaski CR, Lat I, MacLaren R, Poston J. Pharmacist contributions as members of the multidisciplinary ICU team. Chest. 2013;144(5):1687\u201395.","journal-title":"Chest"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00909-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-019-00909-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00909-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T23:11:19Z","timestamp":1602025879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-019-00909-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,8]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["909"],"URL":"https:\/\/doi.org\/10.1007\/s11096-019-00909-0","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,8]]},"assertion":[{"value":"16 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study received no specific funding.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}